sequencing

High-throughput screening rapidly evaluates compounds. Biointron integrates HTS to identify promising leads and guide efficient antibody development.

Single-cell antibody sequencing reveals repertoire diversity. Biointron applies this method to uncover potent candidates for therapeutic antibody programs.

Analytical tools define antibody quality. Biointron applies SPR, BLI, and mass spectrometry to deliver precise characterization and support therapeutic success.

From hybridoma to recombinant platforms, Biointron leads innovations in antibody production and engineering, enabling faster, more flexible, and reliable research solutions.